...
首页> 外文期刊>Investigative ophthalmology & visual science >Frequent mutations of genes involved in OXPHOS and optic neuropathy detected by whole exome sequencing of 257 Glaucoma Patients
【24h】

Frequent mutations of genes involved in OXPHOS and optic neuropathy detected by whole exome sequencing of 257 Glaucoma Patients

机译:257例青光眼患者全外显子组测序发现OXPHOS和视神经病变相关基因的频繁突变

获取原文

摘要

Purpose : Glaucoma is a common disease with characteristic optic neurodegeneration and associated visual dysfunction. Mitochondrial oxidative phosphorylation (OXPHOS) system play critical roles in human neurodegenerative diseases. Mutations of several genes involved in OXPHOS or optic neuropathy have been identified in patients with glaucoma. This study aims to evaluate systemically mutations of genes involved in OXPHOS and optic neuropathy in a cohort of glaucoma patients. Methods : Information of genes involved in OXPHOS and optic neuropathy were obtained based on Pubmed and google scholar research. Variants in 192 genes from 257 Chinese patients with primary glaucoma were selected from our previous whole exome sequencing data. The variants were filtered through multi-step bioinformatics analysis. Results : A total of 90 rare functional mutations in 35 of the 192 genes were detected in 87 of 257 patients with glaucoma. The mutation frequency of these genes were significantly different between patients with glaucoma and subjects enrolled in Exome Aggregation Consortium (P0.001). The most frequent mutant genes were DMPK (14, 5.4%), FGFR2 (7, 2.7%), DNMT1 (6, 2.3%), and PLA2G6 (5, 1.9%). Analysis of the association between these mutations and phenotype is on the way. Conclusions : The high mutation frequency of genes associated with OXPHOS and optic neuropathy in patients with glaucoma suggests that mutational pressure in these genes might be common risk factors for glaucoma. These novel findings need be validated in different ethnic groups. This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.
机译:目的:青光眼是一种常见的疾病,具有特征性视神经变性和相关的视觉功能障碍。线粒体氧化磷酸化(OXPHOS)系统在人类神经退行性疾病中起关键作用。在青光眼患者中已经发现了涉及OXPHOS或视神经病变的几种基因的突变。这项研究旨在评估青光眼患者队列中涉及OXPHOS和视神经病变的基因的系统突变。方法:根据Pubmed和Google学者的研究,获得涉及OXPHOS和视神经病变的基因信息。从我们以前的全外显子组测序数据中选择了257名中国原发性青光眼患者的192个基因的变异。通过多步生物信息学分析过滤变异体。结果:在257例青光眼患者中的87个中,共检测到192个基因中的35个中的90个罕见功能性突变。这些基因的突变频率在青光眼患者和外显子聚集协会的受试者之间有显着差异(P <0.001)。最常见的突变基因是DMPK(14,5.4%),FGFR2(7,2.7%),DNMT1(6,2.3%)和PLA2G6(5,1.9%)。正在对这些突变与表型之间的关联进行分析。结论:青光眼患者中与OXPHOS和视神经病变相关的基因突变频率很高,提示这些基因的突变压力可能是青光眼的常见危险因素。这些新颖的发现需要在不同种族中得到验证。这是提交给2016年5月1-5日在华盛顿州西雅图市举行的2016 ARVO年会的摘要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号